{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:34:39Z","timestamp":1787236479696,"version":"build-2736575974"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15H02563, 17K11119, 18K09157, and 19H05556"],"award-info":[{"award-number":["15H02563, 17K11119, 18K09157, and 19H05556"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.urolonc.2020.06.032","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T08:12:23Z","timestamp":1595491943000},"page":"191.e9-191.e16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Gu\u00e9rin therapy"],"prefix":"10.1016","volume":"39","author":[{"given":"Naoki","family":"Fujita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Hatakeyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Okita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Momota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Tobisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohru","family":"Yoneyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayato","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Yoneyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuaki","family":"Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Ohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.urolonc.2020.06.032_bib0001","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1111\/iju.14105","article-title":"Practice pattern of non-muscle invasive bladder cancer in Japan, Korea and Taiwan: A Web-based survey","volume":"26","author":"Choo","year":"2019","journal-title":"Int J Urol"},{"key":"10.1016\/j.urolonc.2020.06.032_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.urolonc.2020.03.009","article-title":"Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guerin in patients with high-risk non-muscle-invasive bladder cancer","author":"Fujita","year":"2020","journal-title":"Urol Oncol"},{"issue":"5","key":"10.1016\/j.urolonc.2020.06.032_bib0003","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.eururo.2019.08.016","article-title":"European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update","volume":"76","author":"Babjuk","year":"2019","journal-title":"Eur Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2020.06.032_bib0004","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/bju.14915","article-title":"Update on the guideline of guidelines: non-muscle-invasive bladder cancer","volume":"125","author":"Taylor","year":"2020","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.urolonc.2020.06.032_bib0005","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2217\/1750743X.1.2.281","article-title":"Bacillus Calmette-Guerin immunotherapy for urothelial carcinoma of the bladder","volume":"1","author":"Kresowik","year":"2009","journal-title":"Immunotherapy"},{"issue":"6","key":"10.1016\/j.urolonc.2020.06.032_bib0006","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/S0022-5347(17)41343-7","article-title":"Class I and class II HLA antigen expression by transitional cell carcinoma of the bladder: correlation with T-cell infiltration and BCG treatment","volume":"141","author":"Stefanini","year":"1989","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.urolonc.2020.06.032_bib0007","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0149544","article-title":"Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected]","volume":"11","author":"Hatakeyama","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.urolonc.2020.06.032_bib0008","article-title":"Preoperative chronic kidney disease predicts poor prognosis in patients with primary non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor","author":"Fujita","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urolonc.2020.06.032_bib0009","doi-asserted-by":"crossref","first-page":"29466","DOI":"10.1038\/srep29466","article-title":"Areca Nut Chewing and an Impaired Estimated Glomerular Filtration Rate as Significant Risk Factors for Non-Muscle-Invasive Bladder Cancer Recurrence","volume":"6","author":"Cao","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.urolonc.2020.06.032_bib0010","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.2215\/CJN.00950208","article-title":"Aspects of immune dysfunction in end-stage renal disease","volume":"3","author":"Kato","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.urolonc.2020.06.032_bib0011","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/s41598-017-01532-7","article-title":"Prognostic value of impaired estimated glomerular filtration rate in intravesical BCG-treated non-muscle-invasive bladder cancer patients","volume":"7","author":"Tae","year":"2017","journal-title":"Sci Rep"},{"issue":"6","key":"10.1016\/j.urolonc.2020.06.032_bib0012","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"10.1016\/j.urolonc.2020.06.032_bib0013","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/sj.bmt.1705727","article-title":"Competing risk analysis using R: an easy guide for clinicians","volume":"40","author":"Scrucca","year":"2007","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.urolonc.2020.06.032_bib0014","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A Proportional Hazards Model for the Subdistribution of a Competing Risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"issue":"28","key":"10.1016\/j.urolonc.2020.06.032_bib0015","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.urolonc.2020.06.032_bib0016","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1172\/JCI116202","article-title":"Characterization of the internalization of bacillus Calmette-Guerin by human bladder tumor cells","volume":"91","author":"Kuroda","year":"1993","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.urolonc.2020.06.032_bib0017","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.bjc.6602026","article-title":"Role of urothelial cells in BCG immunotherapy for superficial bladder cancer","volume":"91","author":"Bevers","year":"2004","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.urolonc.2020.06.032_bib0018","first-page":"611","article-title":"Novel insights into the mechanism of action of intravesical immunomodulators","volume":"19","author":"Mitropoulos","year":"2005","journal-title":"In Vivo"},{"issue":"5","key":"10.1016\/j.urolonc.2020.06.032_bib0019","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/1097-0215(20010601)92:5<697::AID-IJC1245>3.0.CO;2-Z","article-title":"NK cells are essential for effective BCG immunotherapy","volume":"92","author":"Brandau","year":"2001","journal-title":"Int J Cancer"},{"issue":"1","key":"10.1016\/j.urolonc.2020.06.032_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1043-4666(02)00490-8","article-title":"Role of Th1 and Th2 cytokines in BCG-induced IFN-gamma production: cytokine promotion and simulation of BCG effect","volume":"21","author":"Luo","year":"2003","journal-title":"Cytokine"},{"issue":"1","key":"10.1016\/j.urolonc.2020.06.032_bib0021","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.eururo.2011.09.026","article-title":"Markers predicting response to bacillus Calmette-Guerin immunotherapy in high-risk bladder cancer patients: a systematic review","volume":"61","author":"Zuiverloon","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.urolonc.2020.06.032_bib0022","doi-asserted-by":"crossref","first-page":"35214","DOI":"10.1038\/srep35214","article-title":"Prognostic Value of Pre-operative Renal Insufficiency in Urothelial Carcinoma: A Systematic Review and Meta-Analysis","volume":"6","author":"Cao","year":"2016","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.urolonc.2020.06.032_bib0023","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1111\/j.1523-1755.2004.00465.x","article-title":"Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease","volume":"65","author":"Oberg","year":"2004","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.urolonc.2020.06.032_bib0024","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: how are they linked?","volume":"49","author":"Reuter","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.urolonc.2020.06.032_bib0025","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3592042","article-title":"DNA Damage in Chronic Kidney Disease: Evaluation of Clinical Biomarkers","volume":"2016","author":"Schupp","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.urolonc.2020.06.032_bib0026","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.archger.2016.10.007","article-title":"Frailty and chronic kidney disease: A systematic review","volume":"68","author":"Chowdhury","year":"2017","journal-title":"Arch Gerontol Geriatr"},{"issue":"10","key":"10.1016\/j.urolonc.2020.06.032_bib0027","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12032-019-1313-x","article-title":"Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers","volume":"36","author":"Soma","year":"2019","journal-title":"Med Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2020.06.032_bib0028","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.juro.2013.01.089","article-title":"Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder","volume":"190","author":"Kluth","year":"2013","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.urolonc.2020.06.032_bib0029","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.urolonc.2020.02.016","article-title":"Type 2 diabetes mellitus predicts worse outcomes in patients with high-grade T1 bladder cancer receiving bacillus Calmette-Gu\u00e9rin after transurethral resection of the bladder tumor","volume":"38","author":"Ferro","year":"2020","journal-title":"Urol Oncol"},{"issue":"2","key":"10.1016\/j.urolonc.2020.06.032_bib0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.urpr.2017.02.012","article-title":"Association between Metabolic Syndrome and Recurrence of Nonmuscle Invasive Bladder Cancer following bacillus Calmette-Gu\u00e9rin Treatment","volume":"5","author":"Lenis","year":"2018","journal-title":"Urol Pract"},{"issue":"1","key":"10.1016\/j.urolonc.2020.06.032_bib0031","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.eururo.2011.03.051","article-title":"Bacillus Calmette-Gu\u00e9rin without maintenance therapy for high-risk non-muscle-invasive bladder cancer","volume":"60","author":"Herr","year":"2011","journal-title":"Eur Urol"},{"issue":"3","key":"10.1016\/j.urolonc.2020.06.032_bib0032","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1016\/j.clgc.2019.01.007","article-title":"Determinants of Guideline-Based Treatment in Patients With cT1 Bladder Cancer","volume":"17","author":"Balakrishnan","year":"2019","journal-title":"Clin Genitourin Cancer"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920303197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143920303197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:19:27Z","timestamp":1761041967000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143920303197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1078143920303197"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.06.032","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of chronic kidney disease on oncological outcomes in patients with high-risk non-muscle-invasive bladder cancer who underwent adjuvant bacillus Calmette-Gu\u00e9rin therapy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2020.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}